Green Thumb Industries (GTBIF) Accumulated Expenses (2019 - 2026)
Green Thumb Industries (GTBIF) posted Accumulated Expenses of $75.3 million for Q1 2026, down 14.95% on a QoQ basis from $88.5 million in Q4 2025, and down 1.88% year-over-year from $76.7 million in Q1 2025.
Green Thumb Industries (GTBIF) Accumulated Expenses (2019 - 2026) Analysis & Trends
Green Thumb Industries' Accumulated Expenses history runs 8 years deep, the most recent figure standing at $75.3 million for Q1 2026.
- Quarterly Accumulated Expenses fell 1.88% year-over-year to $75.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.3 million (down 1.88% YoY) and the FY2025 annual result came in at $88.5 million, up 2.71% from the prior year.
- Accumulated Expenses was $75.3 million for Q1 2026 at Green Thumb Industries, down from $88.5 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $116.9 million in Q2 2023 and bottomed at $59.6 million in Q4 2023.
- A 5-year average of $80.2 million and a median of $76.7 million in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Accumulated Expenses soared 54.25% — and 2024, when it tumbled 46.29%.
- Green Thumb Industries' Accumulated Expenses stood at $87.0 million in 2022, then sank by 31.53% to $59.6 million in 2023, then surged by 44.68% to $86.2 million in 2024, then rose by 2.71% to $88.5 million in 2025, then slipped by 14.95% to $75.3 million in 2026.
- Business Quant data shows GTBIF's Accumulated Expenses at $75.3 million in Q1 2026, $88.5 million in Q4 2025, and $82.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.27 Mn |
| Dec 31, 2025 | 88.50 Mn |
| Sep 30, 2025 | 82.76 Mn |
| Jun 30, 2025 | 73.65 Mn |
| Mar 31, 2025 | 76.71 Mn |
| Dec 31, 2024 | 86.16 Mn |
| Sep 30, 2024 | 75.58 Mn |
| Jun 30, 2024 | 62.78 Mn |
| Mar 31, 2024 | 68.24 Mn |
| Dec 31, 2023 | 59.55 Mn |
| Sep 30, 2023 | 86.47 Mn |
| Jun 30, 2023 | 116.89 Mn |
| Mar 31, 2023 | 99.92 Mn |
| Dec 31, 2022 | 86.97 Mn |
| Sep 30, 2022 | 71.52 Mn |
| Jun 30, 2022 | 75.78 Mn |
| Mar 31, 2022 | 77.21 Mn |
| Dec 31, 2021 | 84.72 Mn |
| Sep 30, 2021 | 78.70 Mn |
| Jun 30, 2021 | 72.89 Mn |